Analyst Price Target is $17.00
▲ +191.60% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Nemaura Medical in the last 3 months. The average price target is $17.00, with a high forecast of $17.00 and a low forecast of $17.00. The average price target represents a 191.60% upside from the last price of $5.83.
Current Consensus is
The current consensus among 1 contributing investment analysts is to buy stock in Nemaura Medical.